Back to Search
ALISON LOREN, MD
MD
Hematology & Oncology Physician
NPI: 1942241641IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD065936L(PA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Class of 1996
Research & Publications (20)
Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.
PMID 18026156·Bone Marrow Transplant·2008
6-review
Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation.
PMID 16785065·Biol Blood Marrow Transplant·2006
8-other
Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation.
PMID 16462177·Curr Opin Oncol·2006
6-review
Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation.
PMID 15765118·Bone Marrow Transplant·2005
8-other
Efficacy of HPA-1a (PlA1)-negative platelets in a patient with post-transfusion purpura.
PMID 15224362·Am J Hematol·2004
5-case
Retransplantation of a cardiac allograft inadvertently harvested from a donor with metastatic melanoma.
PMID 12973122·Transplantation·2003
5-case
Post-transplant lymphoproliferative disorder: a review.
PMID 12621474·Bone Marrow Transplant·2003
6-review
Determination and distribution of diesel components in igneous rock surrounding underground diesel storage facilities in Sweden.
PMID 11347612·Environ Sci Technol·2001
8-other
Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies.
PMID 19652524·Cancer Biol Ther·2009
8-other
Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality.
PMID 18819096·Am J Hematol·2008
5-case
Severe eosinophilia as a manifestation of acute graft-versus-host disease.
PMID 18791329·Oncology·2008
5-case
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia.
PMID 18765556·Clin Cancer Res·2008
3-trial
Lethal vascular leak syndrome after denileukin diftitox administration to a patient with cutaneous gamma/delta T-cell lymphoma and occult cirrhosis.
PMID 18335564·Am J Hematol·2008
5-case
Differentiation syndrome in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
PMID 18181037·Med Oncol·2008
5-case
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support.
PMID 17696204·Am J Hematol·2007
8-other
Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
PMID 17204865·Cancer Biol Ther·2007
5-case
Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapy.
PMID 17187896·J Am Acad Dermatol·2007
5-case
Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation.
PMID 16770314·Bone Marrow Transplant·2006
8-other
A predictive model for the detection of tumor lysis syndrome during AML induction therapy.
PMID 16753873·Leuk Lymphoma·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 SPRUCE ST, 15 PENN TOWER
PHILADELPHIA, PA 19104 - Phone
- (215) 662-3914
Quick Facts
- NPI
- 1942241641
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile